Peripartum Pharmacotherapy: A Pharmacist's Guide
- PMID: 36427222
- DOI: 10.1177/08971900221142681
Peripartum Pharmacotherapy: A Pharmacist's Guide
Abstract
Complications throughout the peripartum period may be caused by preexisting conditions or pregnancy-induced conditions and may alter pharmacotherapy management. Pharmacotherapy management during late pregnancy and delivery requires careful consideration due to changing hormones, hemodynamic status, and pharmacokinetics, and concerns for potential maternal and/or fetal morbidity. Increased maternal and fetal monitoring are often required and may lead to therapy changes. Pharmacists, as key members of the interprofessional team, can contribute essential perspective to the management of postpartum pharmacotherapy through assessment and recommendation of appropriate and judicious use of medications.
Keywords: intrapartum; labor and delivery; peripartum; postpartum.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: The authors have the following conflicts of interest to disclose:Kylie Barnes – consultant for Wolters Kluwer Lauren Leader – consultant for Wolters Kluwer and Pfizer Julie Kelsey – consultant for Wolters Kluwer and Pfizer stockholder.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources